Long-term efficacy, tolerability and overall survival in patients (pts) with unresectable or metastatic (U/M) PDGFRA D842V-mutant gastrointestinal stromal tumour (GIST) treated with avapritinib: NAVIGATOR phase I trial update Meeting Abstract
| Authors: | Kang, Y. K.; Jones, R. L.; von Mehren, M.; Serrano, C.; George, S.; Heinrich, M. C.; Schoffski, P.; Mir, O.; Cassier, P. A.; Eskens, F.; Rutkowski, P.; Tap, W. D.; Chawla, S. P.; Shi, H.; Roche, M.; Bauer, S. |
| Abstract Title: | Long-term efficacy, tolerability and overall survival in patients (pts) with unresectable or metastatic (U/M) PDGFRA D842V-mutant gastrointestinal stromal tumour (GIST) treated with avapritinib: NAVIGATOR phase I trial update |
| Meeting Title: | ESMO Asia Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2020 Nov 20-22 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-11-01 |
| Start Page: | S1287 |
| End Page: | S1288 |
| Language: | English |
| ACCESSION: | WOS:000600988900117 |
| DOI: | 10.1016/j.annonc.2020.10.136 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 115MO -- Source: Wos |
